Lishan Aklog - May 7, 2024 Form 4 Insider Report for Lucid Diagnostics Inc. (LUCD)

Role
Chief Executive Officer, Director
Signature
/s/ Michael A. Gordon, by power of attorney
Stock symbol
LUCD
Transactions as of
May 7, 2024
Transactions value $
$0
Form type
4
Date filed
5/8/2024, 04:00 PM
Previous filing
May 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUCD Common stock Award $0 +400K +52.18% $0.00 1.17M May 7, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2026. Such restricted stock is subject to forfeiture if the requisite service period is not completed.
F2 Includes 142,227 shares of Lucid common stock distributed by PAVmed on February 15, 2024 to Dr. Aklog, representing his share of the shares of Lucid common stock distributed by PAVmed to its shareholders on a pro rata basis on such date.